West Pharmaceutical holds 2026 annual meeting; all proposals pass except shareholder chair proposal

WEST PHARMACEUTICAL SERVICES INC

Eleven directors elected to one-year terms; all received majority support with >57M votes each.
Non-binding say-on-pay approved with 60.1M for, 3.8M against, 80K abstain.
Ratification of PwC as auditor for FY2026 passed with 58.5M for, 7.6M against.
Shareholder proposal for independent board chair policy not approved: 29.6M for, 34.2M against.
Total shares represented: 66.2M (91.83% of outstanding).

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

WEST PHARMACEUTICAL SERVICES INC shareholders approved Ratification of appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for fiscal 2026 at the 2026-05-04 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2026-05-04

Exact text from the filing

Proposal 3: The appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the 2026 fiscal year was ratified as set forth below.

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

WEST PHARMACEUTICAL SERVICES INC shareholders rejected Shareholder proposal regarding an Independent Board Chair Policy at the 2026-05-04 meeting.

Outcome: failed
Meeting: 2026-05-04

Exact text from the filing

Proposal 4: The shareholder proposal regarding an Independent Board Chair Policy was not approved as set forth below.

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

WEST PHARMACEUTICAL SERVICES INC shareholders approved Non-binding advisory vote to approve the compensation of the Company's named executive officers at the 2026-05-04 meeting.

Proposal: say on pay
Outcome: passed
Meeting: 2026-05-04

Exact text from the filing

Proposal 2: The non-binding advisory vote to approve the compensation of the Company's named executive officers was approved as set forth below.

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

WEST PHARMACEUTICAL SERVICES INC shareholders approved Election of eleven nominees as directors to serve until the 2027 Annual Meeting of Shareholders at the 2026-05-04 meeting.

Proposal: director election
Outcome: passed
Meeting: 2026-05-04

Exact text from the filing

Proposal 1: The eleven nominees, as set forth below and in the Company's 2026 Proxy Statement, were elected as directors, each to serve until the 2027 Annual Meeting of Shareholders.

View on SEC.gov

1183 shareholder votes filed in the last 30 days. Browse all shareholder votes →

WEST PHARMACEUTICAL SERVICES INC filing history →

Source: SEC EDGAR

accession 0000105770-26-000056

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.